Detalhe da pesquisa
1.
Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients.
Ann Hematol
; 94(8): 1319-26, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25869029
2.
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).
Ann Hematol
; 93(6): 965-75, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24682421
3.
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
Ann Hematol
; 95(1): 153-154, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26442854
4.
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia.
Leukemia
; 20(10): 1783-9, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16838027
5.
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial.
Leukemia
; 20(10): 1723-30, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16932345
6.
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.
Lancet
; 365(9460): 657-62, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15721470
7.
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.
Leukemia
; 19(8): 1479-82, 2005 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15973451
8.
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
Leukemia
; 19(11): 1929-33, 2005 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16151466
9.
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups.
Leukemia
; 19(10): 1768-73, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16079891
10.
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia.
Drugs Today (Barc)
; 52(4): 249-60, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27252989
11.
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
Leukemia
; 30(10): 1987-1992, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27133819
12.
P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.
J Clin Oncol
; 11(12): 2362-9, 1993 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-7504091
13.
Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
J Clin Oncol
; 11(6): 1046-54, 1993 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-8501490
14.
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
J Clin Oncol
; 14(3): 955-62, 1996 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-8622045
15.
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.
J Clin Oncol
; 9(7): 1210-4, 1991 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-2045861
16.
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
J Clin Oncol
; 9(3): 432-7, 1991 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-1999712
17.
Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
J Clin Oncol
; 5(9): 1356-63, 1987 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-3476689
18.
Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphoma.
J Clin Oncol
; 2(2): 98-101, 1984 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-6366149
19.
Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
Curr Med Res Opin
; 21(3): 403-11, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15811209
20.
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomas.
Leukemia
; 5 Suppl 1: 38-41, 1991.
Artigo
Inglês
| MEDLINE | ID: mdl-1890864